Literature DB >> 18972378

Gene transfer into neural cells in vitro using adenoviral vectors.

Thomas Southgate1, Kurt M Kroeger, Chunyan Liu, Pedro R Lowenstein, Maria G Castro.   

Abstract

Adenoviral vectors are excellent vehicles to transfer genes into the nervous system due to their ability to transduce dividing and nondividing cells, their ability to be grown to very high titers, and their relatively large insert capacity. Also, adenoviral vectors can sustain very long-term transgene expression in the CNS of rodents and in neurons and glial cells in culture. Successful gene transfer into the nervous system is dependent on the development, production, and quality control of vector preparations, which need to be of the highest quality. This unit provides protocols to clone, rescue, amplify, and purify first-generation adenoviral vectors. Detailed quality control assays are provided to ensure that vector preparations are devoid of contamination from replication-competent adenovirus and lipopolysaccharides. Also included are methodologies related to adenoviral-mediated gene transfer into neurons and glial cells in culture, and the analysis of transgene expression using immunocytochemistry, enzymatic assays, and fluorescence-activated cell sorting (FACS) analysis. Copyright 2008 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18972378      PMCID: PMC2659706          DOI: 10.1002/0471142301.ns0423s45

Source DB:  PubMed          Journal:  Curr Protoc Neurosci        ISSN: 1934-8576


  41 in total

1.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Quantification of adenovirus particles.

Authors:  H Liebermann; R Mentel
Journal:  J Virol Methods       Date:  1994-12       Impact factor: 2.014

4.  Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells.

Authors:  H Lochmüller; A Jani; J Huard; S Prescott; M Simoneau; B Massie; G Karpati; G Acsadi
Journal:  Hum Gene Ther       Date:  1994-12       Impact factor: 5.695

5.  Palindromic adenovirus type 5-simian virus 40 hybrid.

Authors:  Y Gluzman; K Van Doren
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication.

Authors:  R Spessot; K Inchley; T M Hupel; S Bacchetti
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

7.  An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3.

Authors:  A J Bett; W Haddara; L Prevec; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

8.  Expression of dihydrofolate reductase, and of the adjacent EIb region, in an Ad5-dihydrofolate reductase recombinant virus.

Authors:  K L Berkner; P A Sharp
Journal:  Nucleic Acids Res       Date:  1984-02-24       Impact factor: 16.971

9.  Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone.

Authors:  G Ketner; F Spencer; S Tugendreich; C Connelly; P Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector.

Authors:  G W Wilkinson; A Akrigg
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

View more
  14 in total

1.  Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen.

Authors:  Gwendalyn D King; A K M Ghulam Muhammad; Daniel Larocque; Kyle R Kelson; Weidong Xiong; Chunyan Liu; Nicholas S R Sanderson; Kurt M Kroeger; Maria G Castro; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

2.  Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.

Authors:  Marianela Candolfi; Gwendalyn D King; Kader Yagiz; James F Curtin; Yohei Mineharu; A K M Ghulam Muhammad; David Foulad; Kurt M Kroeger; Nick Barnett; Regis Josien; Pedro R Lowenstein; Maria G Castro
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

3.  Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.

Authors:  Marianela Candolfi; Kader Yagiz; Mia Wibowo; Gabrielle E Ahlzadeh; Mariana Puntel; Homayon Ghiasi; Neha Kamran; Christopher Paran; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2014-02-05       Impact factor: 12.531

4.  Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms.

Authors:  Neha Kamran; Marianela Candolfi; Gregory J Baker; Mariela Moreno Ayala; Marta Dzaman; Pedro R Lowenstein; Maria G Castro
Journal:  Methods Mol Biol       Date:  2016

5.  Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.

Authors:  Weidong Xiong; Marianela Candolfi; Chunyan Liu; A K M Ghulam Muhammad; Kader Yagiz; Mariana Puntel; Peter F Moore; Julie Avalos; John D Young; Dorothy Khan; Randy Donelson; G Elizabeth Pluhar; John R Ohlfest; Kolja Wawrowsky; Pedro R Lowenstein; Maria G Castro
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

6.  Region-specific genetic alterations in the aging hippocampus: implications for cognitive aging.

Authors:  Corinna Burger
Journal:  Front Aging Neurosci       Date:  2010-10-14       Impact factor: 5.750

7.  Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Fu-Shin X Yu; Maria G Castro; Alexander V Ljubimov
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-11-20       Impact factor: 4.799

8.  Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression.

Authors:  A K M Ghulam Muhammad; Marianela Candolfi; Gwendalyn D King; Kader Yagiz; David Foulad; Yohei Mineharu; Kurt M Kroeger; Katherine A Treuer; W Stephen Nichols; Nicholas S Sanderson; Jieping Yang; Maksim Khayznikov; Nico Van Rooijen; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

9.  Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity.

Authors:  Marianela Candolfi; Kader Yagiz; David Foulad; Gabrielle E Alzadeh; Matthew Tesarfreund; A K M Ghulam Muhammad; Mariana Puntel; Kurt M Kroeger; Chunyan Liu; Sharon Lee; James F Curtin; Gwendalyn D King; Jonathan Lerner; Katsuaki Sato; Yohei Mineharu; Weidong Xiong; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2009-07-01       Impact factor: 12.531

10.  Adenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes.

Authors:  Mehrnoosh Saghizadeh; Andrei A Kramerov; Yousha Yaghoobzadeh; Jinwei Hu; Julia Y Ljubimova; Keith L Black; Maria G Castro; Alexander V Ljubimov
Journal:  Brain Res Bull       Date:  2009-10-12       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.